Could protein kinase inhibitors become a next generation pharmacotherapy for non-Hodgkin's lymphoma?

Expert Opin Pharmacother. 2024 May 13:1-4. doi: 10.1080/14656566.2024.2354915. Online ahead of print.

Authors

Melanie Cohen¹, Solomon A Graf^{2

3

4}

Affiliations

¹ Pharmacy Section, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.
² Hospital and Specialty Medicine, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.
³ Department of Hematology/Oncology, University of Washington School of Medicine, Seattle, WA, USA.
⁴ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

PMID: 38726844
DOI: 10.1080/14656566.2024.2354915

No abstract available

Keywords: B-cell lymphoma; Non-Hodgkin’s; protein kinase; small molecule inhibitors.

Publication types

Editorial